Prevention of stroke in patients with atrial fibrillation
Anticoagulant and antiplatelet options
Journal of Interventional Cardiac Electrophysiology , 05/29/2012
Varughese CJ et al. – The emergence of new anticoagulants that offer equal or superior efficacy, greater safety and the convenience of fixed oral dosing may make warfarin the less preferred option. This review provides an update on recent advancements in antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF).